NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 165 filers reported holding NOVOCURE LTD in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $243,000 | +8.0% | 11,154 | 0.0% | 0.01% | +12.5% |
| Q4 2017 | $225,000 | +1.8% | 11,154 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $221,000 | +14.5% | 11,154 | 0.0% | 0.01% | +14.3% |
| Q2 2017 | $193,000 | +114.4% | 11,154 | 0.0% | 0.01% | +133.3% |
| Q1 2017 | $90,000 | +2.3% | 11,154 | 0.0% | 0.00% | -25.0% |
| Q4 2016 | $88,000 | – | 11,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
| Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
| COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
| GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
| HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
| Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
| Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
| Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |